Navigation Links
YM BioSciences third quarter 2010 operational and financial results
Date:5/13/2010

MISSISSAUGA, ON, May 13 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, TSX:YM), today reported operational and financial results for the third quarter of fiscal 2010, ended March 31, 2010.

"During the third quarter, we completed the merging into YM of Cytopia Limited, now YM BioSciences Australia, expanding our pipeline through the addition of two promising new drug candidates in drug classes that have been established as being of high interest and value to the pharmaceutical industry," said David Allan, Chairman and CEO of YM BioSciences. "With a strengthened balance sheet from our recent financing and a portfolio of four late-stage products, the quality and prospects for our drug portfolio are unmatched in YM's history as a company. This quarter we gathered momentum in for our clinical programs with an expansion of our Phase I/II clinical trial for CYT387 as well as the acceptance and presentation of our data at several international forums. We look forward to numerous clinical and corporate events during the balance of 2010."

Highlights for the third quarter of Fiscal 2010:

    -   Merged Cytopia (now YM BioSciences Australia), a clinical-stage, drug
        development company based in Melbourne, Australia, into YM.

    -   Cleared by the US FDA to enroll patients at US clinical sites into
        two ongoing randomized, double-blind Phase II trials of our lead
        product, nimotuzumab.

    -   Expanded the current Phase I/II clinical trial in myelofibrosis
        through an earlier-than-planned initiation of the Phase II component
        of the study for CYT387, the company's highly selective and potent
        JAK1/2 inhibitor.

    -   Had two posters accepted for presentation at the American Association
        for Cancer Resear
'/>"/>
SOURCE  YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 

Related biology technology :

1. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
2. Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010
3. YM BioSciences announces controlled equity offering
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
5. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
9. YM BioSciences closes US$17.5 million financing
10. YM BioSciences to raise approximately US$15 million
11. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Yongye International, Inc. (NASDAQ: YONG ) ... distributor of crop nutrient products in the ... on May 16, 2013, the special committee (the "Special ... Directors") was provided a letter (the "Letter") issued by ... Limited ("Abax") to Full Alliance International Limited ("Full Alliance"). ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... 17, 2013 The paradigm of ‘one ... systems that can help predict the adverse and therapeutic ... Stepaniants, Head of Computational Biology at the Genomics Laboratory, ... to ensure high-quality genomics when used as part of ... to complex data sets to identify key clinical targets ...
(Date:5/17/2013)... Seattle, WA (PRWEB) May 17, 2013 Rust ... several metals and non-metal home items could be damaged. To ... advised the use of its no-scrubbing rust remover ... would be able available with 10% discount. , My Cleaning ... – by corroding them or by staining them. The ...
Breaking Biology Technology:Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2
... Dr Albert J Ketterman and SHP Parakrama Karunaratne, Dept. of Medical,Parasitology, ... , ... In attempts to control Culex quinquefasciatus as a worldwide vector of , ... , are sprayed with organophosphate insecticides. However, ...
... , and Jef , Raus 1, 2 , 1 ... Universitaire Campus, B-3590 Diepenbeek, Belgium , ... Phenylketonuria (PKU) is a hereditary disease that gives rise to elevated , ... by , mutations in the phenylalanine hydroxylase gene. This ...
... Igarashi , Tochigi Cancer Center, Tochigi, Japan , ... Introduction , Denaturing gradient gel ... used mutation scanning methods. It has evolved enormously over the last , ... A practical method on this topic has been reported recently. 1 ...
Cached Biology Technology:Preparative Nondenaturing Gel Electrophoresis Used in the Purification of an Esterase Involved in Insecticide Resistance, Rev C 2Preparative Nondenaturing Gel Electrophoresis Used in the Purification of an Esterase Involved in Insecticide Resistance, Rev C 3Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System 2Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System 3Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System 4Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System 5Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 2Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 3
(Date:5/17/2013)... Cargo in Efficient and Sustainable Global Logistics Operations) is ... in the efficiency of intermodal loading systems and the ... comprises 29 European organisations with experience in the logistics ... budget totalling 17,000,000 and a duration of three and ... and develop the semantic components and ontologies shared by ...
(Date:5/16/2013)... (May 17, 2013) Illustrating a commitment to ... American Gastroenterological Association (AGA) Research Foundation has announced ... Research Fellowship Award recipients. Supported by the National ... (NIDDK), this new award helps underrepresented minority students ... and nutrition research. , "By establishing this new ...
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2
... Thomas Jefferson University in Philadelphia have shown that a ... prostate cancer cell growth. The researchers, led by Kimmel ... newly found connection will aid in better understanding the ... against the disease. , SIRT1 is a member ...
... in mediating the outcome of competition between rival groups, ... the New World--or, on a much smaller ecological scale, ... competing bacteria. In a new study, researchers have compared ... one another, and they have found that each strategy ...
... professionals and the general public alike have been acutely aware ... pandemic. Although many people might still recall the pandemics of ... possibility of a recurrence on that scale--that causes the most ... exactly how many people died from this particular strain of ...
Cached Biology News:Jefferson scientists find aging gene also protects against prostate cancer development 2Different strategies underlie the ecology of microbial invasions 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3
GBL Antibody...
Human acetylcholine receptor (AChR)-alpha. Exhibits homogenous, high affinity,binding to the receptor. Binds weakly to a64-78. Inhibits binding of many,myasthenia gravis sera to human AChR....
... Mouse monoclonal [SPM278] to 67kD Laminin Receptor, ... carcinoma N592 live cells (Human). Reactivity ... yet tested in other species. Background ... glycoproteins of basement membrane, displays multiple biological ...
... Well BAC Prep; Ideal for ... 1.5ml 2xYT cultures; Provides high-quality ... sequencing for small to large ... which minimizes shearing and improves ...
Biology Products: